Literature DB >> 17172820

Growth inhibitory effects of gastric cancer cells with an increase in S phase and alkaline phosphatase activity repression by aloe-emodin.

Junming Guo1, Bingxiu Xiao, Shun Zhang, Donghai Liu, Yiping Liao, Qian Sun.   

Abstract

Aloe-emodin is a novel active compound found in the root and rhizome of Rheum palmatum. To investigate the effects and mechanisms of aloe-emodin on human gastric cancer, MGC-803 cells were treated with 2.5, 5, 10, 20 and 40 microM aloe-emodin for 1-5 d. The results showed that aloe-emodin inhibited the growth of cancer cells in a dose-dependent manner with an increase in S phase and in the proportion of cells cycling at a higher ploidy level (>G2/M). Moreover, the alkaline phosphatase (ALP) activity, an indicator of cell differentiation, was found decreased. This is one of the first to focus on the effect of ALP activity in human gastric carcinomas cells treated by aloe-emodin. These results indicate that aloe-emodin has a potential value for the treatment of gastric cancer and its mechanisms are by means of cell cycle interruption and induce differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172820     DOI: 10.4161/cbt.6.1.3553

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  9 in total

1.  Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2.

Authors:  Kangdong Liu; Chanmi Park; Shengqing Li; Ki Won Lee; Haidan Liu; Long He; Nak Kyun Soung; Jong Seog Ahn; Ann M Bode; Ziming Dong; Bo Yeon Kim; Zigang Dong
Journal:  Carcinogenesis       Date:  2012-04-24       Impact factor: 4.944

2.  Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation.

Authors:  Xiaobin Chang; Jimin Zhao; Fang Tian; Yanan Jiang; Jing Lu; Junfen Ma; Xiaoyan Zhang; Guoguo Jin; Youtian Huang; Zigang Dong; Kangdong Liu; Ziming Dong
Journal:  Oncol Lett       Date:  2016-07-25       Impact factor: 2.967

3.  Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide.

Authors:  Ying Miao; Bingxiu Xiao; Zhen Jiang; Yanan Guo; Fang Mao; Junwei Zhao; Xia Huang; Junming Guo
Journal:  Med Oncol       Date:  2009-08-11       Impact factor: 3.064

4.  Lycium barbarum Polysaccharides Protect Rat Corneal Epithelial Cells against Ultraviolet B-Induced Apoptosis by Attenuating the Mitochondrial Pathway and Inhibiting JNK Phosphorylation.

Authors:  Shaobo Du; Biao Han; Kang Li; Xuan Zhang; Xueli Sha; Lan Gao
Journal:  Biomed Res Int       Date:  2017-07-17       Impact factor: 3.411

5.  Aloesin Suppresses Cell Growth and Metastasis in Ovarian Cancer SKOV3 Cells through the Inhibition of the MAPK Signaling Pathway.

Authors:  Li-Qian Zhang; Rong-Wei Lv; Xiang-Dong Qu; Xian-Jun Chen; Hong-Sheng Lu; Ying Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2017-06-18       Impact factor: 2.916

6.  Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis.

Authors:  Yuan Zhou; Rong Wu; Fei-Fei Cai; Wen-Jun Zhou; Yi-Yu Lu; Hui Zhang; Qi-Long Chen; Ming-Yu Sun; Shi-Bing Su
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

7.  Anticolon Cancer Targets and Molecular Mechanisms of Tao-He-Cheng-Qi Formula.

Authors:  Zexin Zhang; Siqi Lin; Zifeng Liu; Jun Han; Jing Li; Yi Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-18       Impact factor: 2.650

8.  Critical role of cholesterol in bovine herpesvirus type 1 infection of MDBK cells.

Authors:  Liqian Zhu; Xiuyan Ding; Jie Tao; Jianye Wang; Xin Zhao; Guoqiang Zhu
Journal:  Vet Microbiol       Date:  2010-01-11       Impact factor: 3.293

9.  An Investigation of the Antigastric Cancer Effect in Tumor Microenvironment of Radix Rhei Et Rhizome: A Network Pharmacology Study.

Authors:  Xinmiao Wang; Guanghui Zhu; Haoyu Yang; Ruike Gao; Zhe Wu; Ying Zhang; Xiaoyu Zhu; Xiaoxiao Zhang; Jie Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-24       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.